Premium
Role of the Research‐Subject Locator (RSL) in the Performance of a Pediatric Drug Trial
Author(s) -
Wilson J. T.,
Kearns G.,
Springer M. A.
Publication year - 2003
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1177/0091270003258191
Subject(s) - officer , schema (genetic algorithms) , clinical trial , subject (documents) , medicine , financial compensation , house officer , medical education , compensation (psychology) , family medicine , psychology , computer science , social psychology , political science , library science , law , machine learning
This article examines the feasibility, effectiveness, and ethical constraints relevant to appropriate financial compensation of the pediatric house officer who functions as a research‐subject locator (RSL). When carefully trained and supervised, the RSL can facilitate timely enrollment of research subjects in pediatric drug trials, augment the house officer training experience, and advocate for children to increase therapeutic options available for pediatric care. When monitored within the clinical trial schema, the RSL has no direct link to the study outcome and thus performs within ethical standards for subject enrollment and study participation.